Preclinical and early clinical activity of the oral selective inhibitor of nuclear export (SINE) exportin I (XPOI) antagonist KPT-330 (Selinexor) in patients (pts) with platinum-resistant/refractory ovarian cancer (OvCa) Meeting Abstract
| Authors: | Martignetti, J.; Razak, A. R. A.; Chen, Y.; Gabrail, N. Y.; Gerecitano, J. F.; Camacho, C.; Pereira, E.; Dottino, P. R.; Shacham, S.; McCauley, D.; Rashal, T.; Saint-Martin, J. R.; Shacham, E.; Vincett, D.; Kauffman, M.; Mirza, M. R.; Sorensen, M. |
| Abstract Title: | Preclinical and early clinical activity of the oral selective inhibitor of nuclear export (SINE) exportin I (XPOI) antagonist KPT-330 (Selinexor) in patients (pts) with platinum-resistant/refractory ovarian cancer (OvCa) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203506 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.5522 |
| Notes: | Meeting Abstract: 5522 -- Source: Wos |
